Stent maker CardioMind starts trial, gets $22M
See our story about this Sunnyvale, Calif., medical-device maker at VentureBeat LifeScience.
Next Story: Stent maker CardioMind starts trial, gets $22M
Previous Story: Triage Wireless gets $20M for vital-signs monitors
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.